Clinical data | |
---|---|
Trade names | Dynocard |
Other names | Gitoxin 3′,3′,3′′′,4′′′′,16-pentaformate |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.030.397 |
Chemical and physical data | |
Formula | C46H64O19 |
Molar mass | 920.999 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Gitoformate (INN, or pentaformylgitoxin, trade name Dynocard) is a cardiac glycoside, a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat).[1] Produced by Madaus, it is not available in the US, and does not seem to be available in Europe either.